Find clinical trials for Non-Small-Cell Lung Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near New York, NY, USA:
The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung ....
Phase 2
New York, New York, United States and 9 other locations
body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung cancer (NSCLC) t...
Phase 2
New York, New York, United States and 8 other locations
3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous NSCL...
Phase 1
New York, New York, United States and 36 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
New York, New York, United States and 90 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
New York, New York, United States and 124 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
The Bronx, New York, United States and 210 other locations
with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) wi...
Phase 2
New York, New York, United States and 61 other locations
HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...
Phase 1
New York, New York, United States and 21 other locations
is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung Cancer (NSCLC). This...
Phase 1
New York, New York, United States and 28 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
New York, New York, United States and 126 other locations
Clinical trials
Research sites
Resources
Legal